News - Panthera Bio

Panthera Biopartners appoints Martyn Jellett as Associate Director Business Development to support growing commercial team

April 2, 2024March 27, 2024

Independent clinical trial SMO (Site Management Organisation) Panthera Biopartners has appointed Martyn Jellett as Associate Director Business Development to support its expanding commercial team as the company continues to prosper and expand. Martyn has over 25 years experience in professional sales and business development and has extensive knowledge of the pharmaceutical and medical industry. Panthera, …

International Clinical Trials (ICT): Panthera interview

March 14, 2024March 1, 2024

International Clinical Trials (ICT): Panthera interview – Private vs public vaccine studies, how SMOs can secure the future of UK clinical trials Panthera’s Ian Smith and Chris Dodd recently spoke to ICT about the differences in private versus public clinical trials, how speed is key in preclinical processes and how the UK can improve its …

Panthera bucks the trend and brings vaccine trials to the UK

November 23, 2023October 12, 2023

Panthera Biopartners has become a world leader in running international vaccine studies. In the last 18 months, Panthera has run eight vaccine studies at its network of clinical trial sites across the UK on behalf of the pharma industry. Panthera’s sites are regularly first in the world or first in the UK in treating the …

CLINICAL TRIALS SPECIALIST WINS TOP INDUSTRY AWARD

November 23, 2023October 12, 2023

Preston-based Panthera Biopartners has been named Pharma Research Centre of the Year at the Pharma Industry Awards UK 2023. The award was given in recognition of the company’s innovative SMO (Site Management Organisation) model, which focuses on speed of start-up, access to more than a million patients – many prequalified – and digitisation of contact and qualification of patients …

Management In Practice – Manchester

July 25, 2023

Our dedicated patient engagement team, comprising Chris Dodd, Erik Farish, and Sairah Yassir-Deane, had an enriching experience at the ‘Management in Practice’ event in Manchester. We had the opportunity to interact with numerous General Practitioners (GPs) from across the UK, who are keen to introduce the concept of patient engagement in clinical research to their …

Clinical Trials News: July 2023

July 20, 2023

Panthera finds quality patients fast Since its launch in 2019 Panthera has concentrated on building access to patients. Today Panthera has not only access to the largest qualified patient pool in the UK – NHS or SMO – but has also built a network of GP practices including some of the leading mega GP practices providing …

Panthera contributes to Lord O’Shaughnessy’s independent review into UK clinical trials

July 20, 2023March 27, 2023

Lord James O’Shaughnessy, former Health Minister, has been appointed by the UK government to conduct an independent review of the country’s commercial clinical trials landscape. The review will advise on how to resolve key challenges in conducting commercial clinical trials and ensure that the UK remains a global leader in the field. Lord O’Shaughnessy’s advice is expected to be published this spring.

Responsible Growth Priorities And The Hybridized Trial Of The Future.

March 27, 2023February 20, 2023

Dr Ian Smith (Co-founder, Director and Chief Medical Officer) and Chris Dodd (Chief Commercial Officer) recently spoke to Jo Shorthouse at In Vivo to discuss the practicalities and reality of running clinical trial sites as a business, the efficiencies found with the SMO model, the challenge of patient recruitment as well as the decentralized and hybridized trial model. To listen to the …

UK independent clinical trial sites running research on new medicines continue to prosper despite the decline at NHS sites

January 17, 2023

The independent Site Management Organisations (SMOs) which run clinical trials on behalf of the pharmaceutical industry continue to expand not only the number of trials being brought to the UK but also the number of patients enrolled.

Speeding up trial enrolment can save billions

November 2, 2022November 2, 2022

New data show that the site management model reduces start-up times for a Phase II or Phase III clinical trial by up to nine months compared to UK public sites, representing billions in savings Panthera identifies likely patients seven months before public sector sites start planning their recruitment campaigns. The loss of nine months patent …

Work with Us